Scientists have discovered the structure and operating procedures of a powerful antibacterial killing machine that could become an alternative to antibiotics.
In research published in the Proceedings of the National Academy of Science, scientists from Monash University, the Rockefeller University and the University of Maryland detail how the bacteriophage lysin, PlyC, kills bacteria that cause infections from sore throats to pneumonia and streptococcal toxic shock syndrome.
Bacteriophages, viruses that specifically infect and kill bacteria using special proteins called lysins, have been investigated as possible treatments since 1919. However, with the discovery of antibiotics in the 1940s, 'phage therapy' was generally abandoned.
In collaboration with professor Vince Fischetti at Rockefeller and Dr. Dan Nelson at Maryland, Monash researchers professor James Whisstock, associate professor Ashley Buckle and Dr. Sheena McGowan from the School of Biomedical Sciences, have spent the last six years deciphering the atomic structure of PlyC, to better understand its remarkable antibacterial properties.
McGowan says PlyC looked a little like a spaceship. "PlyC is actually made from nine separate protein parts that assemble to form a very effective bacterial killing machine. It actually resembles a flying saucer carrying two warheads," McGowan says. "It operates by locking onto the bacterial surface using eight separate docking sites located on one face of the saucer. The two warheads can then chew through the surface of the cell, rapidly killing the bacteria."
Buckle says the PlyC, which attacks the streptococci bacteria, was a very promising target for the future development of new drugs. "PlyC, in its purified form, has been shown to be 100 times more efficient at killing certain bacteria than any other lysin to date even faster than household bleach."
First identified in 1925, PlyC was purified in the 1960s by Professor Fischetti, but its atomic structure proved elusive until now.
"Scientists have been trying to decipher the structure of PlyC for more than 40 years. Finally knowing what it looks like, and how it attacks bacteria, is a huge step forward," McGowan says.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.